<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The obstetric management of the pregnant rheumatic patient is largely dictated by the specific disease and the degree to which it is associated with recognizable and treatable adverse obstetric outcomes, maternal or fetal </plain></SENT>
<SENT sid="1" pm="."><plain>This review will cover the obstetric management of women with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS), <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA) and systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> (SSc) </plain></SENT>
<SENT sid="2" pm="."><plain>Most experts agree that a co-ordinated management effort on the part of obstetricians and rheumatologists will likely yield the optimal achievable results </plain></SENT>
</text></document>